138 related articles for article (PubMed ID: 2110572)
1. Effects of verapamil on diurnal and thyrotropin-releasing hormone-stimulated prolactin levels in man.
Nielsen-Kudsk JE; Bartels PD; Dalby J
J Clin Endocrinol Metab; 1990 May; 70(5):1269-72. PubMed ID: 2110572
[TBL] [Abstract][Full Text] [Related]
2. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
Kamal TJ; Molitch ME
Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of verapamil on diurnal and thyrotropin releasing hormone stimulated thyrotropin levels in man.
Nielsen-Kudsk JE; Bartels PD
Thyroidology; 1990 Apr; 2(1):13-6. PubMed ID: 1715745
[TBL] [Abstract][Full Text] [Related]
4. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
Ekman AC; Vakkuri O; Ekman M; Leppäluoto J; Ruokonen A; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
[TBL] [Abstract][Full Text] [Related]
5. Calcium and prolactin secretion in humans: effects of the channel blocker, verapamil, in the spontaneous and drug-induced hyperprolactinemia.
Knoepfelmacher M; Villares SM; Nicolau W; Germek OO; Lerário AC; Wajchenberg BL; Liberman B
Horm Metab Res; 1994 Oct; 26(10):481-5. PubMed ID: 7851873
[TBL] [Abstract][Full Text] [Related]
6. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
7. Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone- and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects.
Barbarino A; De Marinis L
J Clin Endocrinol Metab; 1980 Oct; 51(4):749-53. PubMed ID: 6774993
[TBL] [Abstract][Full Text] [Related]
8. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man.
Veldhuis JD; Borges JL; Drake CR; Rogol AD; Kaiser DL; Thorner MO
J Clin Endocrinol Metab; 1985 Jan; 60(1):144-9. PubMed ID: 3880562
[TBL] [Abstract][Full Text] [Related]
9. Effects of disodium EDTA and calcium infusion on prolactin and thyrotropin responses to thyrotropin-releasing hormone in healthy man.
Dudczak R; Waldhäusl WK; Bratusch-Marrain P
J Clin Endocrinol Metab; 1983 Mar; 56(3):603-7. PubMed ID: 6401762
[TBL] [Abstract][Full Text] [Related]
10. Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man.
Röjdmark S; Andersson DE; Sundblad L
J Clin Endocrinol Metab; 1981 Sep; 53(3):594-8. PubMed ID: 6790560
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
12. Effect of the circulating renin-angiotensin system on prolactin release in humans.
Denolle T; Rohmer V; Saint-Adnré JP; Guyene TT; Galland F; Bigorgne JC; Schambelan M; Corvol P
J Clin Endocrinol Metab; 1990 Jan; 70(1):288-92. PubMed ID: 2104627
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
[TBL] [Abstract][Full Text] [Related]
14. Prolactin response to N3im-methyl-thyrotropin releasing hormone in euthyroid subjects.
Sowers JR; Hershman JM; Carlson HE; Pekary E; Nair MG; Baugh CM
J Clin Endocrinol Metab; 1976 Oct; 43(4):749-55. PubMed ID: 824297
[TBL] [Abstract][Full Text] [Related]
15. Effect of atropine on the diurnal PRL responses to TRH in normal subjects.
Nathan RS; McCarthy T; Jarrett DB
Psychoneuroendocrinology; 1984; 9(3):301-4. PubMed ID: 6436857
[TBL] [Abstract][Full Text] [Related]
16. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
[TBL] [Abstract][Full Text] [Related]
17. U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells.
Smallridge RC; Kiang JG; Gist ID; Fein HG; Galloway RJ
Endocrinology; 1992 Oct; 131(4):1883-8. PubMed ID: 1396332
[TBL] [Abstract][Full Text] [Related]
18. Prolactin release in man: influence of cimetidine, thyrotrophin-releasing hormone and acute hypercalcaemia.
Röjdmark S
Acta Endocrinol (Copenh); 1983 Apr; 102(4):481-5. PubMed ID: 6405569
[TBL] [Abstract][Full Text] [Related]
19. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
Röjdmark S
J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
[TBL] [Abstract][Full Text] [Related]
20. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
